Naltrexone Does Not Cause Tardive Dyskinesia
Naltrexone does not cause tardive dyskinesia. Tardive dyskinesia (TD) is specifically associated with long-term use of dopamine receptor blocking agents (antipsychotics/neuroleptics), not opioid antagonists like naltrexone 1.
Mechanism and Causative Agents
Tardive dyskinesia is an involuntary movement disorder characterized by athetoid or choreic movements, typically in the orofacial region, though it can affect any body part 1. TD is caused by chronic exposure to antidopaminergic medications—specifically dopamine receptor blocking agents (DRBAs) such as typical and atypical antipsychotics 2, 3.
Naltrexone functions as a mu opioid receptor antagonist, not a dopamine receptor blocker 4. The FDA drug label for naltrexone lists common adverse effects including nausea, headache, dizziness, nervousness, fatigue, insomnia, vomiting, anxiety, and somnolence—but makes no mention of tardive dyskinesia or any movement disorders 5.
Evidence from Clinical Use
The evidence actually demonstrates naltrexone being used to treat dyskinesias, not cause them:
- A double-blind, placebo-controlled trial showed that high-dose naltrexone (200 mg/day) combined with low-dose clonazepam significantly improved TD symptoms in patients with schizophrenia (mean TD score decrease of 4.0 ± 3.6) 6
- Another study in Parkinson's disease patients found high-dose naltrexone (250-350 mg/day) had minimal effect on levodopa-induced dyskinesias but was well tolerated with no significant adverse effects 7
- Long-term naltrexone use (up to 300 mg/day for 36 months) in Huntington's disease patients showed no significant hepatotoxicity and was used specifically to treat dyskinesia 8
Important Caveat
One animal study in MPTP parkinsonian monkeys reported an unusual phenomenon where dyskinesias appeared after saline or naltrexone injection alone, but only after repeated co-administration with dopaminergic agents 9. This represents a learned motor response in a specific experimental paradigm and has no clinical relevance to naltrexone causing TD in humans receiving the medication for alcohol or opioid dependence.
Clinical Bottom Line
Naltrexone is safe from a movement disorder perspective. The only medications that cause tardive dyskinesia are dopamine receptor blocking agents—primarily first-generation antipsychotics (haloperidol, chlorpromazine, fluphenazine) and to a lesser extent second-generation antipsychotics (risperidone at higher doses) 1, 2, 3. Metoclopramide, a prokinetic agent with antidopaminergic properties, can also cause TD with chronic use 10.
When prescribing naltrexone for alcohol or opioid dependence, monitor for its actual side effects: hepatotoxicity (check liver function tests at baseline and every 3-6 months), nausea, headache, and mood changes including depression 4, 5. Movement disorders are not a concern with this medication.